Advertisement
Screener

CAREDX, INC. (CDNA) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities

2.8 / 5 stars · 67/118 Roast Me

CAREDX, INC. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities

CAREDX, INC. (CDNA) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 0 shares for the 12-month period ending 2016-12-31, per its 10-K filed 2017-04-21.

Discontinued › Income Statement › Earnings Per Share

us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2017-04-21

  • CAREDX, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2015-09-30 was 0.00 shares, a 100.00% decline year-over-year.
  • CAREDX, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2015-06-30 was 0.00 shares, a 100.00% decline year-over-year.
  • CAREDX, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2014-09-30 was 122.14K shares.
  • CAREDX, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2014-06-30 was 189.73K shares.
  • CAREDX, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2016 was 0.00 shares.
  • CAREDX, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2015 was 0.00 shares, a 100.00% decline from fiscal 2014.
  • CAREDX, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2014 was 134.34K shares.
  • CAREDX, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2013 was 0.00 shares.
Period endIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 monthIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 monthIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 monthIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month
2016-12-310.00 shares
10-K · filed 2017-04-21
2015-12-310.00 shares
10-K · filed 2017-04-21
2015-09-300.00 shares
10-Q · filed 2015-11-13
0.00 shares
10-Q · filed 2015-11-13
2015-06-300.00 shares
10-Q · filed 2015-08-12
0.00 shares
10-Q · filed 2015-08-12
2014-12-31134.34K shares
10-K · filed 2017-04-21
2014-09-30122.14K shares
10-Q · filed 2015-11-13
179.61K shares
10-Q · filed 2015-11-13
2014-06-30189.73K shares
10-Q · filed 2015-08-12
0.00 shares
10-Q · filed 2015-08-12
2013-12-310.00 shares
10-K · filed 2016-03-29
2013-09-300.00 shares
10-Q · filed 2014-11-14
0.00 shares
10-Q · filed 2014-11-14
2013-06-300.00 shares
10-Q · filed 2014-08-28
0.00 shares
10-Q · filed 2014-08-28
2012-12-310.00 shares
10-K · filed 2015-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
VERACYTE, INC. (VCYT)United States$3.904B41.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B